https://www.zacks.com/stock/news/2203637/here-s-why-investors-should-retain-labcorp-lh-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2203637
Dec 29, 2023 - Investors remain optimistic about Labcorp (LH) due to impressive partnerships and expansion efforts in targeted high-growth areas.
zc:6870887007628979569
0
https://www.zacks.com/stock/news/2216443/quest-diagnostics-dgx-advances-in-cancer-research-with-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2216443
Jan 26, 2024 - Quest Diagnostics' (DGX) subsidiary Haystack Oncology collaborates with TriSalus Life Sciences to improve therapeutic options for aggressive forms of cancer.
zc:-6297895288763297711
0
https://www.zacks.com/stock/news/2224681/labcorp-lh-q4-earnings-on-the-horizon-analysts-insights-on-key-performance-measures?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2224681
Feb 12, 2024 - Get a deeper insight into the potential performance of Labcorp (LH) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
zc:7780152891915002612
0
https://www.zacks.com/stock/news/2227695/compared-to-estimates-labcorp-lh-q4-earnings-a-look-at-key-metrics-revised?cid=CS-ZC-FT-fundamental_analysis|nfm-2227695
Feb 19, 2024 - Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:-87990051980329135
0
https://www.zacks.com/stock/news/2239239/are-investors-undervaluing-labcorp-lh-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2239239
Mar 12, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zc:4198390999659575554
0
https://www.zacks.com/stock/news/2242254/labcorp-lh-presents-new-research-on-precision-diagnostics?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2242254
Mar 18, 2024 - Labcorp's (LH) new research shows how biomarker testing can help close testing gaps and guide tailored therapy for patients with epithelial ovarian cancer.
zc:-1116512289988692205
0
https://www.zacks.com/stock/news/2248657/labcorp-lh-to-boost-clinical-diagnostics-with-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2248657
Apr 01, 2024 - The recent deal will augment Labcorp's (LH) laboratory services network and expand access to the company's high-quality clinical laboratory services.
zc:5222757716111729225
0
https://www.zacks.com/stock/news/2263462/3-medical-products-stocks-set-to-beat-this-earnings-season?cid=CS-ZC-FT-earnings_esp-2263462
Apr 26, 2024 - Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.
zc:-4677915270669463577
0
https://www.zacks.com/stock/news/2274863/labcorp-lh-to-assess-preeclampsia-risk-with-new-test?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2274863
May 16, 2024 - Labcorp's (LH) new first-trimester test is the latest addition to its dedication to improving women's health.
zc:5593809265332506696
0
https://www.zacks.com/stock/news/2208988/labcorp-lh-to-expand-clinical-trails-access-with-new-pact?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2208988
Jan 11, 2024 - LabCorp (LH) and Hawthorne Effect hope to enhance decentralized clinical trials by merging existing services and developing fresh, unique service offers.
zc:-3127128354671930310
0